Korro Bio is trading 5.56% up at $12.92, with the catalyst still unconfirmed.

  • No company-specific announcement dated September 8, 2026, clearly explains the gain.
  • The latest update, published August 27, announced CEO Ram Aiyar’s participation in investor conferences on September 9 and 10.
  • Broader U.S. markets are lower, so the move does not appear to track the overall market direction.